Thyroid Cancer Metastatic

1 clinical trials · Condition

Record	Firm	Date
Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas (NCT03732495)	Centre Leon Berard	2019-07-26

Every clearance here is in the API, with alerts when new ones post.